# Post-Stroke Secondary Prevention With Digital Monitoring

Study · id `cardio:ct-nct06837311` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06837311](<https://clinicaltrials.gov/study/NCT06837311>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06837311

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 388 participants.

## Technical summary

Registry record NCT06837311. Randomized; no masking; primary purpose other. Start 2025-03-25 (actual); primary completion 2027-03-25 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 388 participants (planned count; ClinicalTrials.gov record NCT06837311, source copy `cardio:ctgov-nct06837311-2025-07-21`, retrieved 2026-10-26)
- Started: 2025-03-25 (actual) (ClinicalTrials.gov record NCT06837311, source copy `cardio:ctgov-nct06837311-2025-07-21`, retrieved 2026-10-26)
- Primary completion: 2027-03-25 (anticipated) (ClinicalTrials.gov record NCT06837311, source copy `cardio:ctgov-nct06837311-2025-07-21`, retrieved 2026-10-26)
- Completion: 2028-03-25 (anticipated) (ClinicalTrials.gov record NCT06837311, source copy `cardio:ctgov-nct06837311-2025-07-21`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT06837311, source copy `cardio:ctgov-nct06837311-2025-07-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06837311-2025-07-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Post-Stroke Secondary Prevention With Digital Monitoring
- Acronym: PSDM
- Condition: Stroke
- Intervention (Device): Ecological Momentary Assessment (EMA)
- Intervention (Biological): Biological assessment
- Intervention (Behavioral): Psychological examination and Substance Use symptomatology
- Intervention (Other): Treatment as usual (TAU)
- Intervention (Diagnostic test): Expired carbon monoxide (CO)
- Lead sponsor: University Hospital, Bordeaux
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University Hospital, Bordeaux (`cardio:org-university-hospital-bordeaux`)

## Provenance

Content hash: 966ddd7870307d37adc5ea04db317f972baa5c0f76c287b0096a44f6b9b0cda1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
